8 unchanged sentences
None of the underwriting discounts and commissions or offering expenses were incurred or paid, directly or indirectly, to directors or officers of ours or their associates or to persons owning 10% or more of our common stock or to any of our affiliates.
−Removed: As of September 30, 2020, we have used approximately $40.3 million of net offering proceeds primarily for commercialization of OCS Lung, research and development, and general corporate purposes.
+Added: As of March 31, 2021, we have used approximately $55.1 million of net offering proceeds primarily for commercialization of OCS Lung, research and development, and general corporate purposes.
We are holding a significant portion of the remaining net proceeds in money market funds, U.S.
18 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: November 6, 2020
TRANSMEDICS GROUP, INC.
4 unchanged sentences
(Principal Executive Officer)
−Removed: November 6, 2020
/s/ Stephen Gordon
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.